T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| 1 |
JPMorgan Chase
JPM
|
+$1.7B |
| 2 |
Verizon
VZ
|
+$1.36B |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$1.31B |
| 4 |
US Bancorp
USB
|
+$1.29B |
| 5 |
Merck
MRK
|
+$1.23B |
Top Sells
| 1 |
Amazon
AMZN
|
+$5.38B |
| 2 |
Alphabet (Google) Class C
GOOG
|
+$4.57B |
| 3 |
Tesla
TSLA
|
+$3.67B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.43B |
Sector Composition
| 1 | Technology | 26.72% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.69% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
726
Ares Management
ARES
$39.3B
| $39.7M | 0.01% |
579,984
+19,814
| +4% | +$1.36M |
|
727
Interparfums
IPAR
$3.47B
| $39.6M | 0.01% |
410,771
+997
| +0.2% | +$96.2K |
|
728
DocuSign
DOCU
$15.9B
| $39.6M | 0.01% |
714,175
+425,463
| +147% | +$23.6M |
|
729
Eversource Energy
ES
$23.8B
| $39.5M | 0.01% |
471,619
+5,212
| +1% | +$437K |
|
730
Oneok
OKE
$46.2B
| $39.3M | 0.01% |
598,183
+2,688
| +0.5% | +$177K |
|
|
AJRD
731
DELISTED
Aerojet Rocketdyne Holdings, Inc.
AJRD
| $39.3M | 0.01% |
702,154
+608,034
| +646% | +$34M |
|
732
SPX Corp
SPXC
$9.29B
| $39M | 0.01% |
594,547
+1,457
| +0.2% | +$95.7K |
|
733
Kroger
KR
$44.3B
| $38.4M | 0.01% |
861,727
-745
| -0.1% | -$33.2K |
|
734
Haemonetics
HAE
$2.59B
| $38.2M | 0.01% |
485,505
+79,532
| +20% | +$6.26M |
|
735
Addus HomeCare
ADUS
$2.03B
| $38.1M | 0.01% |
383,054
+552
| +0.1% | +$54.9K |
|
736
Crown Holdings
CCK
$11B
| $37.9M | 0.01% |
461,305
+87,009
| +23% | +$7.15M |
|
737
Franklin Resources
BEN
$12.6B
| $37.6M | 0.01% |
1,425,381
-37,084
| -3% | -$978K |
|
|
IGMS
738
DELISTED
IGM Biosciences
IGMS
| $37.5M | 0.01% |
2,206,407
-11,359
| -0.5% | -$193K |
|
739
Allogene Therapeutics
ALLO
$246M
| $37.4M | 0.01% |
5,941,797
+34,481
| +0.6% | +$217K |
|
740
Hexcel
HXL
$4.93B
| $37.3M | 0.01% |
634,076
-130,852
| -17% | -$7.7M |
|
741
Littelfuse
LFUS
$6.54B
| $37.3M | 0.01% |
169,181
-37,859
| -18% | -$8.34M |
|
742
Advanced Energy
AEIS
$5.93B
| $37.2M | 0.01% |
433,135
-29,913
| -6% | -$2.57M |
|
743
Celldex Therapeutics
CLDX
$1.66B
| $37.1M | 0.01% |
833,009
+87,001
| +12% | +$3.88M |
|
744
Euronet Worldwide
EEFT
$3.57B
| $37.1M | 0.01% |
393,133
-40,720
| -9% | -$3.84M |
|
745
Dick's Sporting Goods
DKS
$20.4B
| $37M | 0.01% |
307,403
+26,729
| +10% | +$3.22M |
|
746
Axalta
AXTA
$6.7B
| $36.9M | 0.01% |
1,449,554
-47,279
| -3% | -$1.2M |
|
747
Constellation Energy
CEG
$100B
| $36.9M | 0.01% |
428,245
+3,419
| +0.8% | +$295K |
|
748
Rocket Pharmaceuticals
RCKT
$343M
| $36.9M | 0.01% |
1,886,290
+246,647
| +15% | +$4.83M |
|
749
Casey's General Stores
CASY
$20B
| $36.5M | 0.01% |
162,638
+813
| +0.5% | +$182K |
|
750
D.R. Horton
DHI
$52.5B
| $36.5M | 0.01% |
409,254
-7,711
| -2% | -$687K |
|